MANAGEMENT OF PROLACTINOMA

This publication has 11 references indexed in Scilit:

• Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-acting Non-Ergot Dopamine Agonist CV 205-502
  Annals of Internal Medicine, 1990
• A DOUBLE‐BLIND STUDY COMPARING A NEW NON‐ERGOT, LONG‐ACTING DOPAMINE AGONIST, CV 205‐502, WITH BROMOCRIPTINE IN WOMEN WITH HYPERPROLACTINAEMIA
  Clinical Endocrinology, 1990
• CV 205–502 Treatment of Hyperprolactinemia*
  Journal of Clinical Endocrinology & Metabolism, 1989
• Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine
  Pathology - Research and Practice, 1988
• Prolactin-Lowering Effect of Acute and Once Weekly Repetitive Oral Administration of Cabergoline at Two Dose Levels in Hyperprolactinemic Patients
  Journal of Clinical Endocrinology & Metabolism, 1988
• Osteoporosis in Men with Hyperprolactinemic Hypogonadism
  Annals of Internal Medicine, 1986
• Antimitotic actions of dopaminergic drugs on human pituitary tumors
  Published by Elsevier ,1984
• Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth Hormone
  New England Journal of Medicine, 1983
• Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas
  American Journal of Obstetrics and Gynecology, 1983
• Decreased Bone Density in Hyperprolactinemic Women
  New England Journal of Medicine, 1980